Significant Influence of Accompanying Chronic Hepatitis Status on Recurrence of Hepatocellular Carcinoma After Hepatectomy. Result of Multivariate Analysis

Overview

Journal Ann Surg

Specialty General Surgery

Date 1996 Nov 1

PMID 8916872

Citations 36

Authors

S Ko

Y Nakajima

H Kanehiro

M Hisanaga

Y Aomatsu

T Kin

K Yagura

T Ohyama

K Nishio

K Ohashi

M Sho

T Yamada

H Nakano

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to evaluate the correlation between the histologic status of accompanying chronic hepatitis and the recurrence rate of hepatocellular carcinoma (HCC) after hepatectomy by multivariate analysis.

Summary Background Data: Recent studies have suggested that a considerable number of intrahepatic recurrence of HCC after hepatectomy might be the results of metachronous multicentric hepatocarcinogenesis. The authors hypothesized that the incidence of recurrence due to metachronous multicentric hepatocarcinogenesis would depend on the histologic status of accompanying chronic viral liver disease, which is a main promoter of HCC.

Methods: One hundred ten patients with HCC who underwent curative resection were studied. Histologic status of accompanying chronic hepatitis was classified into the three categories: 1) normal liver or chronic persistent hepatitis (CPH, n = 13), 2) chronic aggressive hepatitis (CAH, n = 50), and 3) liver cirrhosis (LC, n = 47).

Results: The Cox multivariate proportional hazard model showed that the accompanying chronic viral hepatitis status (p = 0.0133), extent of hepatectomy (p = 0.0078), and number of tumors (p = 0.0475) were significantly predictive variables for recurrence-free survival. By the log-rank test, recurrence-free survival rate in patients with CPH was significantly higher than those in patients with CAH (p = 0.0005) and LC (p = 0.0075). Patients with CAH had the lowest recurrence-free survival rate (vs. LC, p = 0.028).

Conclusions: The results of this study indicated the significant influence of histologic activity of hepatitis on recurrence of HCC. This might support the concept of significant contribution of multicentric hepatocarcinogenesis to recurrence of HCC after hepatectomy.

Citing Articles

CT-Based Radiomics Nomogram Improves Risk Stratification and Prediction of Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.

Wu C, Yu S, Zhang Y, Zhu L, Chen S, Liu Y Front Oncol. 2022; 12:896002.

PMID: 35875140 PMC: 9302642. DOI: 10.3389/fonc.2022.896002.

Improvement of Image Quality Using Hybrid Iterative Reconstruction with Noise Power Spectrum Model in Computed Tomography During Hepatic Arteriography.

Hamasaki H, Shirasaka T, Ushijima Y, Akamine H, Takayama Y, Kubo Y J Belg Soc Radiol. 2021; 105(1):43.

PMID: 34611577 PMC: 8447979. DOI: 10.5334/jbsr.2444.

Narrow-Margin Hepatectomy Resulted in Higher Recurrence and Lower Overall Survival for R0 Resection Hepatocellular Carcinoma.

Liu L, Shui Y, Yu Q, Guo Y, Zhang L, Zhou X Front Oncol. 2021; 10:610636.

PMID: 33552983 PMC: 7859433. DOI: 10.3389/fonc.2020.610636.

Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy.

Lai L, Su T, Liang Z, Lu Y, Hou E, Lian Z J Cancer. 2020; 11(22):6642-6652.

PMID: 33046985 PMC: 7545675. DOI: 10.7150/jca.47291.

Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment: A meta-analysis.

Wu J, Yin Z, Cao L, Xu X, Yan T, Liu C Medicine (Baltimore). 2018; 97(28):e11295.

PMID: 29995763 PMC: 6076097. DOI: 10.1097/MD.0000000000011295.

References

Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S . Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res. 1992; 52(13):3674-8. View

Sasaki Y, Imaoka S, Masutani S, Ohashi I, Ishikawa O, Koyama H . Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery. 1992; 112(3):515-21. View

Nagasue N, Kohno H, Chang Y, Taniura H, Yamanoi A, Uchida M . Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg. 1993; 217(4):375-84. PMC: 1242804. DOI: 10.1097/00000658-199304000-00009. View

Ouchi K, Matsubara S, Fukuhara K, Tominaga T, Matsuno S . Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection. Am J Surg. 1993; 166(3):270-3. DOI: 10.1016/s0002-9610(05)80972-9. View

Derenzini M, Trere D, Oliveri F, David E, Colombatto P, Bonino F . Is high AgNOR quantity in hepatocytes associated with increased risk of hepatocellular carcinoma in chronic liver disease?. J Clin Pathol. 1993; 46(8):727-9. PMC: 501457. DOI: 10.1136/jcp.46.8.727. View

Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y . Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer. 1994; 73(4):1149-54. DOI: 10.1002/1097-0142(19940215)73:4<1149::aid-cncr2820730405>3.0.co;2-9. View

Desmet V, Gerber M, Hoofnagle J, Manns M, Scheuer P . Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994; 19(6):1513-20. View

Curley S, Izzo F, Gallipoli A, De Bellis M, Cremona F, Parisi V . Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg. 1995; 222(3):375-80; discussion 380-3. PMC: 1234821. DOI: 10.1097/00000658-199509000-00014. View

De Groote J, Desmet V, GEDIGK P, KORB G, Popper H, POULSEN H . A classification of chronic hepatitis. Lancet. 1968; 2(7568):626-8. DOI: 10.1016/s0140-6736(68)90710-1. View

10.

Craddock V . Liver carcinomas induced in rats by single administration of dimethylnitrosamine after partial hepatectomy. J Natl Cancer Inst. 1971; 47(4):899-907. View

11.

Beasley R, Hwang L, Lin C, Chien C . Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981; 2(8256):1129-33. DOI: 10.1016/s0140-6736(81)90585-7. View

12.

Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K . Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer. Ann Surg. 1984; 199(1):51-6. PMC: 1353257. DOI: 10.1097/00000658-198401000-00009. View

13.

Hsu H, Sheu J, Lin Y, Chen D, Lee C, Hwang L . Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC. Cancer. 1985; 56(3):672-80. DOI: 10.1002/1097-0142(19850801)56:3<672::aid-cncr2820560340>3.0.co;2-v. View

14.

Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N . Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg. 1987; 205(1):33-40. PMC: 1492876. DOI: 10.1097/00000658-198701000-00006. View

15.

Sutton F, Russell N, GUINEE V, Alpert E . Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol. 1988; 6(2):321-8. DOI: 10.1200/JCO.1988.6.2.321. View

16.

Chen M, Hwang T, Jeng L, Jan Y, Wang C, Chou F . Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg. 1989; 124(9):1025-8. DOI: 10.1001/archsurg.1989.01410090031006. View

17.

Bruix J, Barrera J, Calvet X, Ercilla G, Costa J, Sanchez-Tapias J . Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989; 2(8670):1004-6. DOI: 10.1016/s0140-6736(89)91015-5. View

18.

Colombo M, Kuo G, Choo Q, Donato M, Del Ninno E, Tommasini M . Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989; 2(8670):1006-8. DOI: 10.1016/s0140-6736(89)91016-7. View

19.

Simonetti R, Cottone M, Craxi A, Pagliaro L, Rapicetta M, Chionne P . Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet. 1989; 2(8675):1338. DOI: 10.1016/s0140-6736(89)91946-6. View

20.

Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T . Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer. 1990; 65(5):1104-10. DOI: 10.1002/1097-0142(19900301)65:5<1104::aid-cncr2820650511>3.0.co;2-g. View